Opening Bell: Global Rally Slows After Vaccine Reality Check; Gold Rebounds

 | Nov 10, 2020 12:16

  • Investors rotate out of tech shares and into value stocks
  • Questions remain about Pfizer vaccine, tempering risk-on
  • Gold pares losses
  • Key Events/h2

    Monday's global rally weakened in pre-US market trade on Tuesday, but haven assets continue to see increased demand and tech shares remain under pressure as investors realize that what was considered a vaccine breakthrough is called for a smaller coronavirus relief package then what Democrats want. This after the US Federal Reserve warned that if the pandemic’s economic impact worsens in the coming months, the financial markets could be severely hurt.

    McConnell also said that President Donald Trump is within his rights to contest the presidential election results, increasing political instability.

    During Monday's New York session, the S&P 500 index lost record gains made at the open, but still managed to close at a two-month high on unusually high trading volume after the news from Pfizer (NYSE:PFE) that a coronavirus vaccine it is developing with BioNtech (NASDAQ:BNTX) had prevented 90% of infections in a late-stage trial.

    The Dow Jones Industrial Average closed more than 800 points higher, adding 3% to its value, also testing all-time highs.